Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Growth factor receptors as targets for antitumor therapy with monoclonal antibodies.

× No keyword cloud information.

8 in total

Review 1. Head and neck cancer: an evolving treatment paradigm.

Authors: David M Cognetti; Randal S Weber; Stephen Y Lai
Journal: Cancer Date: 2008-10-01 Impact factor: 6.860

Review 2. The biotechnology and applications of antibody engineering.

Authors: R Rapley
Journal: Mol Biotechnol Date: 1995-04 Impact factor: 2.695

3. Effects of 131I-EGF on cultured human glioma cells.

Authors: J Capala; M Pråhl; S Scott-Robson; J Pontén; B Westermark; J Carlsson
Journal: J Neurooncol Date: 1990-12 Impact factor: 4.130

4. Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.

Authors: M Naramura; S D Gillies; J Mendelsohn; R A Reisfeld; B M Mueller
Journal: Cancer Immunol Immunother Date: 1993-10 Impact factor: 6.968

5. Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.

Authors: M Caraglia; P Tagliaferri; P Correale; G Genua; A Pinto; S Del Vecchio; G Esposito; A R Bianco
Journal: Cancer Immunol Immunother Date: 1993-08 Impact factor: 6.968

6. Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.

Authors: A Andersson; J Capala; J Carlsson
Journal: J Neurooncol Date: 1992-11 Impact factor: 4.130

7. Heterogeneity response to afatinib in gastric cancer patient with uncommon epidermal growth factor receptor (EGFR) mutations: a case report.

Authors: Qin Liu; Yang Yang; Xiangshan Fan; Xiaoyan Xin; Qiuyue Pan; Yihong Zhang; Baorui Liu; Jia Wei
Journal: Ann Transl Med Date: 2021-05

8. [Observation - An Favorable Option Forthoracic Dissemination Patients with Lung Adenocarcinoma or Squamous Carcinoma].

Authors: Ying Chen; Wei Li; Wenfang Tang; Xuening Yang; Wenzhao Zhong
Journal: Zhongguo Fei Ai Za Zhi Date: 2018-04-20

8 in total